A team at the Centre de recherche Azrieli du CHU Sainte-Justine has reached a major milestone in understanding a rare and severe form of genetic encephalopathy associated with the DHDDS gene. By developing the first mouse model that faithfully reproduces one of the human forms of the disease, researcher Alexey Pshezhetsky, a professor in the Department of Pediatrics, and Dr. Elsa Rossignol, a professor in the Department of Neuroscience, both at UdeM, provide the scientific community with an unprecedented tool to investigate the biological mechanisms underlying this neurodevelopmental disorder and accelerate the development of new therapeutic strategies.
Novel Mouse Model Advances Understanding of Rare Genetic Encephalopathy
Researchers at the Centre de recherche Azrieli du CHU Sainte-Justine have developed a novel mouse model to study a rare genetic encephalopathy linked to the DHDDS gene. This breakthrough, led by Alexey Pshezhetsky and Dr. Elsa Rossignol, offers new insights into the disorder and potential therapeutic strategies. While the study is not directly related to Iran, advancements in medical research can influence global health initiatives, including those in Iran.
👥 Key Players
📰 What Happened
Researchers have developed a new mouse model that mimics a rare genetic encephalopathy linked to the DHDDS gene, allowing for better understanding and potential treatment options for the disorder.
- The model replicates a human form of the disease.
- It aims to accelerate the development of therapeutic strategies.
💡 Why It Matters
📚 Background
Genetic encephalopathies are severe neurological disorders that can have significant impacts on development and quality of life. Understanding these conditions is crucial for developing effective treatments.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%